Infectious Diseases Now

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Infectious Diseases Now is a journal published by Elsevier BV in France. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 1,640 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2666-9927 · 2666-9919
Country
France
Access
Not open access / not declared
Declared publication charge
1,640 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2021-01-01
  • PUBMED · 2021-01-28
Indexing
MEDLINE · PUBMED
APC
1,640 USD
Declared review time (DOAJ)
—
Actual review time (measured)
72 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

983

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

28

i10-index

108

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
91%
ORCID iDs in current deposits
57%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101775152
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotic Resistance in Bacteria
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
Show all subjects (75)
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • SARS-CoV-2 and COVID-19 Research
  • Orthopedic Infections and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Orthopedic Infections and Treatments
  • Vaccine Coverage and Hesitancy
  • Infectious Diseases and Tuberculosis
  • Antibiotics Pharmacokinetics and Efficacy
  • Orthopedic Infections and Treatments
  • Antibiotics Pharmacokinetics and Efficacy
  • Infection Control in Healthcare
  • Pneumonia and Respiratory Infections
  • Pneumonia and Respiratory Infections
  • Pneumonia and Respiratory Infections
  • COVID-19 epidemiological studies
  • Long-Term Effects of COVID-19
  • Vaccine Coverage and Hesitancy
  • Infective Endocarditis Diagnosis and Management
  • Long-Term Effects of COVID-19
  • HIV/AIDS Research and Interventions
  • Vaccine Coverage and Hesitancy
  • Diverse Scientific and Economic Studies
  • Bacterial Identification and Susceptibility Testing
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Resistance in Staphylococcus
  • Urinary Tract Infections Management
  • Urinary Tract Infections Management
  • Urinary Tract Infections Management
  • Nosocomial Infections in ICU
  • COVID-19 epidemiological studies
  • Nosocomial Infections in ICU
  • COVID-19 epidemiological studies
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Bacterial Infections and Vaccines
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Identification and Susceptibility Testing
  • Respiratory viral infections research
  • Bacterial Infections and Vaccines
  • Infectious Diseases and Tuberculosis
  • Respiratory viral infections research
  • Bacterial Infections and Vaccines
  • Infectious Diseases and Tuberculosis
  • Streptococcal Infections and Treatments
  • Mosquito-borne diseases and control
  • Vector-borne infectious diseases
  • Mosquito-borne diseases and control
  • COVID-19 and Mental Health
  • Tuberculosis Research and Epidemiology
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • Tuberculosis Research and Epidemiology
  • Streptococcal Infections and Treatments
  • Travel-related health issues
  • Mosquito-borne diseases and control
  • Travel-related health issues
  • Tuberculosis Research and Epidemiology
  • Sepsis Diagnosis and Treatment
  • Antimicrobial Resistance in Staphylococcus
  • Respiratory viral infections research
  • Travel-related health issues
  • Cervical Cancer and HPV Research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: